Ge Bai

发表

Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease

P. Bickford, K. Ugen, C. Cao, 2015, PloS one.

Helical Antimicrobial Sulfono-γ-AApeptides.

X. Zuo, C. Cao, Haifan Wu, 2015, Journal of medicinal chemistry.

Production of Class II MHC Proteins in Lentiviral Vector‐Transduced HEK‐293T Cells for Tetramer Staining Reagents

J. Altman, Richard Willis, J. Shires, 2021, Current protocols.

Non-hemolytic α-AApeptides as antimicrobial peptidomimetics.

L. Shaw, C. Cao, L. Harrington, 2011, Chemical communications.

Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease

Heng-Liang Wu, K. Ugen, C. Cao, 2014, Human vaccines & immunotherapeutics.

Cellular translocation of a γ-AApeptide mimetic of Tat peptide.

Rongsheng E. Wang, Robert W Buzzeo, C. Cao, 2012, Molecular pharmaceutics.

Cellular uptake of an α-AApeptide.

Rongsheng E. Wang, Robert W Buzzeo, C. Cao, 2012, Organic & biomolecular chemistry.

Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents.

L. Shaw, C. Cao, W. Burda, 2012, Journal of medicinal chemistry.

Lipidated peptidomimetics with improved antimicrobial activity.

Rongsheng E. Wang, C. Cao, Jianfeng Cai, 2012, ACS medicinal chemistry letters.

Design and synthesis of unprecedented cyclic γ-AApeptides for antimicrobial development

Rongsheng E. Wang, C. Cao, Y. Niu, 2012 .

Identification of γ-AApeptides with potent and broad-spectrum antimicrobial activity.

L. Shaw, C. Cao, W. Burda, 2011, Chemical communications.

γ-AApeptide-based small-molecule ligands that inhibit Aβ aggregation.

C. Cao, J. Tipton, Y. Niu, 2014, Chemical communications.

Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease

K. Ugen, C. Cao, J. Sanchez-Ramos, 2015, Human vaccines & immunotherapeutics.

Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer’s Disease in APP+PS1 Mice

Shufeng Zhou, C. Cao, Neel R Nabar, 2012, PloS one.

Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice

Shufeng Zhou, C. Cao, Neel R Nabar, 2012, Journal of Neuroimmune Pharmacology.

The potential therapeutic effects of THC on Alzheimer's disease.

C. Cao, Neel R Nabar, Jianfeng Cai, 2014, Journal of Alzheimer's disease : JAD.

High Blood caffeine levels in MCI linked to lack of progression to dementia.

D. Loewenstein, R. Duara, B. Small, 2012, Journal of Alzheimer's disease : JAD.

Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.

C. Cao, G. Arendash, M. Mamcarz, 2011, Journal of Alzheimer's disease : JAD.

Efficacy of a Therapeutic Vaccine Using Mutated β-amyloid Sensitized Dendritic Cells in Alzheimer’s Mice

Shufeng Zhou, C. Cao, Neel R Nabar, 2012, Journal of Neuroimmune Pharmacology.

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera

C. Cao, Jianfeng Cai, Junping Wang, 2015, BMC Immunology.

Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.

C. Cao, G. Arendash, Xiaoyang Lin, 2011, Journal of Alzheimer's disease : JAD.

COPD_A_334439 3285..3295

W. Zou, P. Ran, Sha Liu, 2021 .

Polymer-Encapsulated Aβ Peptide Fragments as an Oligomeric-Specific Vaccine for Alzheimer's Disease.

K. Breitenkamp, C. Cao, Jianfeng Cai, 2016, Journal of biomedical nanotechnology.